Nitric oxide exerts antiviral effects by S-nitrosylating the active site cysteine of viral proteases, a mechanism that may broadly apply to antimicrobial host defenses.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for nitric oxide-mediated antiviral defense in animals; leaves open translation to human viral infections.
Although nitric oxide (NO) kills or inhibits the replication of a variety of intracellular pathogens, the antimicrobial mechanisms of NO are unknown. Here, we identify a viral protease as a target of NO. The life cycle of many viruses depends upon viral proteases that cleave viral polyproteins into individual polypeptides. NO inactivates the Coxsackievirus protease 3C, an enzyme necessary for the replication of Coxsackievirus. NO S-nitrosylates the cysteine residue in the active site of protease 3C, inhibiting protease activity and interrupting the viral life cycle. Substituting a serine residue for the active site cysteine renders protease 3C resistant to NO inhibition. Since cysteine proteases are critical for virulence or replication of many viruses, bacteria, and parasites, S-nitrosylation of pathogen cysteine proteases may be a general mechanism of antimicrobial host defenses.
No takes yet. Share an insight, caveat, or question.
Saura et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: